购物车
- 全部删除
- 您的购物车当前为空
Kv7.2/Kv7.3 agonist 1 (Compound 16) 作为一种口服激动剂,针对KV7.2/7.3通道(KV7.2/7.3 channel/KCNQ2/3),其EC50值为1.03 μM。在实验动物模型中,该化合物在小鼠的慢性压迫性损伤(CCI)和Streptozotocin诱导的糖尿病周围神经性疼痛(DPNP)模型中具有显著的镇痛效果,ED50值分别达到12.02和9.63 mg/kg。
Kv7.2/Kv7.3 agonist 1 (Compound 16) 作为一种口服激动剂,针对KV7.2/7.3通道(KV7.2/7.3 channel/KCNQ2/3),其EC50值为1.03 μM。在实验动物模型中,该化合物在小鼠的慢性压迫性损伤(CCI)和Streptozotocin诱导的糖尿病周围神经性疼痛(DPNP)模型中具有显著的镇痛效果,ED50值分别达到12.02和9.63 mg/kg。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Kv7.2/Kv7.3 agonist 1 (Compound 16) is an orally effective agonist for the KV7.2/7.3 channels (KV7.2/7.3 channel/KCNQ2/3) with an EC50 of 1.03 μM. This compound demonstrates analgesic effects in mouse models of chronic constriction injury (CCI) and Streptozotocin-induced diabetic peripheral neuropathy (DPNP), with ED50 values of 12.02 mg/kg and 9.63 mg/kg, respectively. |
靶点活性 | KCNQ2/Q3:1.03 μM (EC50) |
分子量 | 275.28 |
分子式 | C14H14FN3O2 |
CAS No. | 2315450-35-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容